Cognitive Behavioral Therapy (CBT)

Cognitive Behavioral Therapy (CBT) is one of the most extensively studied, structured, and effective psychotherapeutic approaches for the treatment of major depressive disorder. It is an empirically-based intervention founded on well-established theoretical models that link thoughts, emotions, and behaviors to the origin and maintenance of affective disorders.

It is recommended as a first-line treatment in international guidelines (NICE, APA, CANMAT) for mild to moderate depression, and in combination with pharmacological therapy in severe or treatment-resistant cases.

Theoretical model and rationale

CBT is based on the assumption that depressive symptoms are maintained by dysfunctional cognitive schemas (beliefs) and by avoidant or self-limiting behaviors, often developed through personal experience. In response to negative events, individuals may activate automatic negative thoughts (“I’m worthless,” “things will never get better,” “it’s all my fault”) that fuel dysphoric emotions and behaviors of withdrawal or passivity. This creates a vicious cycle that maintains or worsens the depressive state.

The central goal of CBT is to identify and modify these distorted thoughts through cognitive restructuring techniques, promoting a more realistic and flexible view of the self, others, and the future. At the same time, behavioral interventions encourage gradual activation, social reintegration, and the recovery of rewarding activities, helping to break the cycle of passivity and resignation.

Mechanisms of action in depression

CBT works at multiple levels of psychological functioning. On the cognitive level, it reduces the negative bias typical of depression by targeting the tendency to generalize, think dichotomously, and draw catastrophic conclusions. Through Socratic questioning, the therapist helps the patient question the accuracy and usefulness of their thoughts, encouraging the development of more functional alternative interpretations.

On the behavioral level, CBT promotes gradual activation and the overcoming of avoidance, through the planning of graded tasks, monitoring of pleasure/mastery, and reinforcement of positive behaviors. This process helps to reverse anhedonia and apathy, restoring a sense of personal efficacy and control.

On the metacognitive level, CBT addresses ruminative thinking styles common in depression, teaching strategies to disengage from intrusive mental content and develop a more flexible and mindful relationship with internal experiences.

Treatment structure

CBT for depression typically follows a manualized and short-term structure, consisting of 12–20 weekly sessions. It is divided into three main phases:

• Initial phase (Sessions 1–4): building therapeutic alliance, psychoeducation on the cognitive model of depression, identification of automatic negative thoughts.
• Core phase (Sessions 5–14): cognitive restructuring, behavioral activation, analysis and modification of dysfunctional schemas.
• Consolidation phase (Sessions 15–20): relapse prevention, generalization of learned skills, identification of early relapse signs and maintenance planning.

Each session follows a defined structure (agenda, homework review, technique application, summary), which helps the patient feel actively involved and fosters a sense of mastery over the therapeutic process.

Clinical indications

CBT is indicated for a wide range of depressive presentations. In mild to moderate depression, it serves as a first-line alternative to pharmacotherapy, while in moderate-to-severe depression it is recommended in combination with antidepressants, as the combined approach yields superior outcomes compared to either intervention alone.

It is particularly useful for patients presenting with:

• High ruminative tendencies or recurring negative thoughts;
• Persistent dysfunctional cognitive styles (e.g., low self-esteem, guilt, rigid perfectionism);
• Impaired social functioning due to avoidance or behavioral passivity;
• Strong motivation for treatment and willingness to actively participate.

CBT is also used for relapse prevention in patients with recurrent depression, often through structured programs such as Mindfulness-Based Cognitive Therapy (MBCT).

Efficacy and guidelines

Numerous randomized controlled trials and meta-analyses have confirmed the effectiveness of CBT in reducing depressive symptoms, with response and remission rates comparable to or exceeding antidepressants in mild-to-moderate depression. The benefits tend to persist over time, particularly in patients who complete the full course and acquire stable cognitive and behavioral coping skills.

According to the National Institute for Health and Care Excellence (NICE) guidelines, CBT is the psychological treatment of choice for adults with moderate or severe depression, and may be offered as monotherapy in mild cases. The American Psychiatric Association (APA) and the Canadian Network for Mood and Anxiety Treatments (CANMAT) also list CBT as a first-line intervention, both in acute treatment and relapse prevention.

CBT has demonstrated specific effectiveness in reducing the risk of relapse, exceeding that of pharmacotherapy alone after antidepressant discontinuation. The active learning of self-regulation strategies and cognitive tools represents a long-term protective factor.

Final considerations

CBT is a structured, short-term, and evidence-based therapy with high efficacy in treating depression. It is suitable for motivated patients who are capable of introspection and willing to engage in active work between sessions. Therapeutic alliance, shared understanding of the depressive model, and personalized goals are central to therapeutic success.

In clinical practice, CBT functions not only as a symptom-focused treatment but also as an educational and transformative intervention that equips patients with stable tools to recognize, manage, and prevent depressive relapses. When delivered with methodological rigor, it is one of the most effective and enduring tools for managing mood disorders.

References
1. Beck AT et al. Cognitive therapy of depression. New York: Guilford Press. 1979.
2. Cuijpers P et al. The effects of cognitive behavior therapy for adult depression are probably overestimated. Psychol Med. 2016;46(16):3265–3277.
3. Butler AC et al. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006;26(1):17–31.
4. National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management. NICE guideline [NG222]. 2022.
5. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. 2010.
6. Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the management of adults with major depressive disorder. Can J Psychiatry. 2016;61(9):510–523.
7. Hollon SD et al. Cognitive therapy and medication in the treatment and prevention of depression. Depress Anxiety. 2005;22(4):204–214.
8. Segal ZV et al. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. New York: Guilford Press. 2002.
9. Dobson KS. A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol. 1989;57(3):414–419.
10. Gloaguen V et al. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49(1):59–72.